U. D. Larsen

1.0k total citations
19 papers, 762 citations indexed

About

U. D. Larsen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, U. D. Larsen has authored 19 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Oncology. Recurrent topics in U. D. Larsen's work include Metabolism, Diabetes, and Cancer (5 papers), Pancreatic function and diabetes (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). U. D. Larsen is often cited by papers focused on Metabolism, Diabetes, and Cancer (5 papers), Pancreatic function and diabetes (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). U. D. Larsen collaborates with scholars based in Denmark, Norway and Australia. U. D. Larsen's co-authors include Jan Markussen, Inge Jonassen, Ulla Ribel, Peter Kurtzhals, Svend Havelund, Bénédicte Kiehr, Asser S. Andersen, Knud Vad, E. Hasselager and V. Kruse and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Scientific Reports.

In The Last Decade

U. D. Larsen

18 papers receiving 718 citations

Peers

U. D. Larsen

MB

EDM

SURGE

GENET

RNMI

A.R. Sørensen Denmark

Bénédicte Kiehr Denmark

Clement W.T. Yeung Canada

Bruno Hansen Denmark

Gyohan Koh Japan

B Sepehrnia United States

Emília Kletvíková United Kingdom

Thomas Kruse Denmark

H. Neal Bramson United States

P. Thamm Germany

A.R. Sørensen Denmark

U. D. Larsen

409 ×1.0

MB

325 ×0.8

EDM

282 ×1.0

SURGE

116 ×1.3

GENET

40 ×0.5

RNMI

Citations per year, relative to U. D. Larsen U. D. Larsen (= 1×) peers A.R. Sørensen

Countries citing papers authored by U. D. Larsen

Since Specialization

Citations

This map shows the geographic impact of U. D. Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. D. Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. D. Larsen more than expected).

Fields of papers citing papers by U. D. Larsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. D. Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. D. Larsen. The network helps show where U. D. Larsen may publish in the future.

Co-authorship network of co-authors of U. D. Larsen

This figure shows the co-authorship network connecting the top 25 collaborators of U. D. Larsen. A scholar is included among the top collaborators of U. D. Larsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. D. Larsen. U. D. Larsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Larsen, U. D., et al.. (2025). Mapping the initial effects of carcinogen-induced oncogenic transformation in the mouse bladder. Experimental Cell Research. 446(2). 114452–114452. 1 indexed citations

2.

Larsen, U. D., et al.. (2025). Efficient cytoplasmic cell quantification using a semi-automated FIJI-based tool. Scientific Reports. 15(1). 27509–27509.

3.

Pedersen, Mette Lund, et al.. (2003). [¹²⁵I], [¹²⁷I]‐and [¹⁴C]‐Labelling of the GLP‐1‐(7‐37) derivative NN2211. Journal of Labelled Compounds and Radiopharmaceuticals. 46(6). 499–510. 4 indexed citations

4.

Larsen, U. D., et al.. (2000). [125I]- and [14C]-labelling of the long-acting insulin derivative NN304. Journal of Labelled Compounds and Radiopharmaceuticals. 43(7). 671–682. 1 indexed citations

5.

Larsen, U. D., et al.. (1999). Determination of in vitro plasma protein binding of insulin aspart and insulin detemir by equilibrium dialysis. 1. 236. 4 indexed citations

6.

Markussen, Jan, Svend Havelund, Peter Kurtzhals, et al.. (1996). Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs. Diabetologia. 39(3). 281–288. 191 indexed citations

7.

Markussen, Jan, Svend Havelund, Peter Kurtzhals, et al.. (1996). Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs. Diabetologia. 39(3). 281–288. 17 indexed citations

8.

Kurtzhals, Peter, Svend Havelund, Inge Jonassen, et al.. (1995). Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochemical Journal. 312(3). 725–731. 287 indexed citations

9.

Larsen, U. D., et al.. (1993). Characterization of the three 125I-iodination isomers of human insulin-like growth factor I (IGF1). Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1203(2). 205–209. 15 indexed citations

10.

Schäffer, L., Thomas Kjeldsen, Asser S. Andersen, et al.. (1993). Interactions of a hybrid insulin/insulin-like growth factor-I analog with chimeric insulin/type I insulin-like growth factor receptors.. Journal of Biological Chemistry. 268(5). 3044–3047. 11 indexed citations

11.

Moody, Alison, Thure Krarup, & U. D. Larsen. (1992). The reactivity of anti-porcine gastric inhibitory polypeptide (GIF) rabbit serum R65 with synthetic human and porcine GIF. Scandinavian Journal of Clinical and Laboratory Investigation. 52(2). 103–106. 2 indexed citations

12.

Kruse, V., et al.. (1991). Scintigraphic Studies in Rats: Kinetics of Insulin Analogues Covering Wide Range of Receptor Affinities. Diabetes. 40(5). 628–632. 15 indexed citations

13.

Larsen, U. D., et al.. (1991). Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatoma HepG2 cells. Diabetes. 40(11). 1488–1495. 18 indexed citations

14.

Drejer, Kirsten, V. Kruse, U. D. Larsen, et al.. (1991). Receptor Binding and Tyrosine Kinase Activation by Insulin Analogues With Extreme Affinities Studied in Human Hepatoma HepG2 Cells. Diabetes. 40(11). 1488–1495. 78 indexed citations

15.

Sonne, Ole, et al.. (1982). The Effect of Oxidation of the Met²⁷Residue of [¹²⁵I]Monoiodoglucagon on Receptor-Binding Affinity. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 363(1). 95–102. 15 indexed citations

16.

Larsen, U. D., et al.. (1980). Homogeneous mono-125I-insulins. Diabetologia. 19(6). 546–54. 70 indexed citations

17.

Naithani, Vinod Κ., et al.. (1975). Studies on Polypeptides, VII. Synthesis, Circular Dichroism and Immunological Studien of Tyrosyl C-Peptide of Human Proinsulin. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 356(2). 1305–1312. 6 indexed citations

18.

Jørgensen, Aksel, et al.. (1969). Metabolism, Distribution and Excretion of Flupenthixol. Acta Pharmacologica et Toxicologica. 27(5). 301–313. 22 indexed citations

19.

Forshell, Gustaf Plym, et al.. (1968). Distribution and Metabolism of 3,3‐dimethyl‐1‐(3‐methylaminopropyl)‐1‐phenyl‐phthalane (Lu 3‐010), a Bicyclic Compound with Thymoleptic Properties. Acta Pharmacologica et Toxicologica. 26(6). 507–520. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact